• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The potential economic value of influenza vaccination for healthcare workers in the Netherlands

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2018 Apr 6. doi: 10.1111/irv.12558. [Epub ahead of print]
[h=1]The potential economic value of influenza vaccination for healthcare workers in the Netherlands.[/h] Meijboom MJ[SUP]1,[/SUP][SUP]2[/SUP], Riphagen-Dalhuisen J[SUP]1,[/SUP][SUP]2[/SUP], Hak E[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Despite the clinical evidence, influenza vaccination coverage of healthcare workers remains low. To assess the health economic value of implementing an influenza immunization program among healthcare workers (HCW) in University Medical Centers (UMCs) in the Netherlands, a cost-benefit model was developed using a societal perspective.
[h=4]METHODS/PATIENTS:[/h] The model was based on a trial performed among all UMCs in the Netherlands that included both hospital staff as well as patients admitted to the pediatrics and internal medicine departments. The model structure and parameters estimates was based on the trial and complemented with literature research, and the impact of uncertainty explored with sensitivity analyses.
[h=4]RESULTS:[/h] In a base-case scenario without vaccine coverage, influenza related annual costs were estimated at ? 410,815 for an average UMC with 8,000 HCWs and an average occupancy during the influenza period of 6,000 hospitalized patients. Of these costs, 82% attributed to the HCWs and 18% were patient related. With a vaccination coverage of 15.47%, the societal program's savings were ? 2,861 which corresponds to a saving of ? 270.53 per extended hospitalization. Univariate sensitivity analyses show that the results are most sensitive to changes in the model parameters vaccine effectiveness in reducing influenza-like-illness (ILI) and the vaccination-related costs.
[h=4]CONCLUSION:[/h] In addition to the decreased burden of patient morbidity among hospitalized patients, the effects of the hospital immunization program slightly outweigh the economic investments. These outcomes may support healthcare policy makers' recommendations about the influenza vaccination program for healthcare workers. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Economic value; healthcare workers; hospital; implementation; influenza; patients; vaccination

PMID: 29624882 DOI: 10.1111/irv.12558
Free full text
 
Back
Top Bottom